Login to Your Account

Other News To Note

Monday, August 6, 2012
• Catalyst Pharmaceutical Partners Inc., of Coral Gables, Fla., reported that it has regained compliance with the $1 minimum bid price requirement for continued listing on the Nasdaq Capital Market. The company's shares trade under the symbol CPRX.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription